CDK1 in Breast Cancer: Implications for Theranostic PotentialSepideh Izadi, Farhad Jadidi‐Niaragh, Gholamreza Azizi et al.|Anti-Cancer Agents in Medicinal Chemistry|2020Cited by 169
Prostaglandin E2 as a potent therapeutic target for treatment of colon cancerVahid Karpisheh, Farhad Jadidi‐Niaragh, Gholamreza Azizi et al.|Prostaglandins & Other Lipid Mediators|2019Cited by 126
Downregulation of A2AR by siRNA loaded PEG-chitosan-lactate nanoparticles restores the T cell mediated anti-tumor responses through blockage of PKA/CREB signaling pathwayAli Masjedi, Farhad Jadidi‐Niaragh, Hadi Hassannia et al.|International Journal of Biological Macromolecules|2019Cited by 81
S1PR1 as a Novel Promising Therapeutic Target in Cancer TherapyNarges Rostami, Farhad Jadidi‐Niaragh, Afshin Nikkhoo et al.|Molecular Diagnosis & Therapy|2019Cited by 73
Smac mimetics as novel promising modulators of apoptosis in the treatment of breast cancerAfshin Nikkhoo, Farhad Jadidi‐Niaragh, Narges Rostami et al.|Journal of Cellular Biochemistry|2018Cited by 27